(Q43232927)

16 November 2017

title

Markers of the hepatic component of the metabolic syndrome as predictors of mortality in renal transplant recipients (English)

1 reference

16 November 2017

1 reference

4

1 reference

16 November 2017

E Corpeleijn

2

0 references

author name string

D M Zelle

1

1 reference

16 November 2017

R M van Ree

3

1 reference

16 November 2017

E van der Veer

5

1 reference

16 November 2017

R O B Gans

6

1 reference

16 November 2017

J J Homan van der Heide

7

1 reference

16 November 2017

G Navis

8

1 reference

16 November 2017

S J L Bakker

9

1 reference

16 November 2017

language of work or name

English

0 references

publication date

24 November 2009

1 reference

American Journal of Transplantation

16 November 2017

published in

1 reference

16 November 2017

volume

10

1 reference

16 November 2017

issue

1

1 reference

16 November 2017

page(s)

106-114

1 reference

Cardiovascular complications after renal transplantation and their prevention.

16 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

Metabolic cardiovascular syndrome after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

Fatty liver: a novel component of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

AGA technical review on nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

Review: The role of insulin resistance in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

Diagnosis and therapy of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

Non-alcoholic fatty liver disease: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

Gamma glutamyl transferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

Gamma-glutamyltransferase and diabetes--a 4 year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

Gamma-glutamyl transpeptidase and the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

Abdominal obesity and smoking are important determinants of C-reactive protein in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

Accelerated atherosclerosis in patients with Wegener's granulomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

Is serum gamma glutamyltransferase a marker of oxidative stress?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

Cytosolic triglycerides and oxidative stress in central obesity: the missing link between excessive atherosclerosis, endothelial dysfunction, and beta-cell failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2009.02876.X

10.1111/J.1600-6143.2009.02876.X

21 January 2018

Identifiers

DOI

1 reference

16 November 2017

1 reference